Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Appropriate Management of Bacteriemic Febrile Neutropenia in High-Risk Hematological Patients. Relationship Between Duration of Antibiotic Administration, Outcome and Resistance Profile

NCT07372131 is registered in ClinicalTrials.gov with Valeria Cento as lead sponsor.

NCT NCT07372131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07372131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Appropriate Management of Bacteriemic Febrile Neutropenia in High-Risk Hematological Patients. Relationship Between Duration of Antibiotic Administration, Outcome and Resistance Profile
Lead sponsor
Valeria Cento
Phase
Not applicable
Overall status
Recruiting
Start date
February 2, 2026
Completion date
November 30, 2028
Enrollment
172 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacteraemia caused by gram-negative bacteria, bloodstream infection, febrile neutropenia (fn), gram negative infections